A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer
Clinical trial NCT03026166 · TERMINATED
Trial details
- NCT number
- NCT03026166
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-30
- Primary completion
- 2019-07-03
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.